SAPCD2 further promotes progression and metastasis in different human types of cancer by activating the Wnt/β-catenin, JAK/STAT, TGF-β, MAPK, and NF-κB signaling pathways, all of which have been reported to play crucial roles in cancer progression and metastasis (35–40). The gene discussed is NFKB1; the disease is cancer.